Shopping Cart
Remove All
Your shopping cart is currently empty
Synonyms:
KRAS-IN-54
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | KRAS-IN-54 is a macrocyclic inhibitor of KRAS that shows activity in cell viability and pERK inhibition assays specifically targeting KRASG12D and KRASG13D mutations. It is applicable in research on KRAS-mutant cancers, including pancreatic adenocarcinoma, colorectal cancer, non-small cell lung cancer, esophageal cancer, gallbladder cancer, melanoma, ovarian cancer, and endometrial cancer. |
| In vitro | KRAS-IN-54 (compound 3) inhibits the viability of AGS (KRAS G12D) cells with an IC50 of 10 nM and also inhibits the viability of HCT-116 (KRAS G13D) cells with an IC50 of 27 nM. Furthermore, KRAS-IN-54 suppresses ERK phosphorylation in AGS (KRAS G12D) cells with an IC50 of 9 nM and in HCT-116 (KRAS G13D) cells with an IC50 of 10 nM. |
| Molecular Weight | 1192.39 |
| Formula | C60H78F5N11O7S |
| Cas No. | 3084918-70-4 |
| Smiles | O=C1OCC(C)(C)CC=2C=3C=C(C(F)=CC3N(C2C4=CC(=CN=C4C(OC)C)N5CCN(C)CC5)CC(F)(F)F)C=6N=C(SC6)CC(NC(=O)C(N(C(=O)C7(F)CCN(C(=O)C8N(C)C8C9CC9)CC7)C)C%10CCCC%10)C(=O)N%11NC1CCC%11 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 µL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 µL Tween 80 and mix well until fully clarified.
3) Add 450 µL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.